Andere talen Sansure Biotech Inc.

Aandelen

688289

CNE1000043J1

Medische apparatuur, benodigdheden & distributie

Slotkoers Shanghai S.E. Andere beurzen 04-03-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
18,04 ^CNY	-0,22%		-7,39%	-4,60%

27/02	Sansure Biotech Inc. rapporte de jaarresultaten voor het volledige boekjaar afgesloten op 31 december 2025	CI
27/02	Sansure Biotech-dochteronderneming krijgt goedkeuring voor proef met groeihormooninjectie als behandeling voor ISS	MT

Andere talen

27/02	Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
27/02	Sansure Biotech's Subsidiary Gets Nod to Trial Growth Hormone Injection As ISS Treatment
17/12	Sansure Biotech Gets China Nod for Four Testing Kits
03/11	Sansure Biotech Gets Registration Certificates for Pathogen Detection Kits
30-10-25	Sansure Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025
22-10-25	Sansure Biotech to Set Up Medical Tech Partnership Fund
23-09-25	Sansure Biotech Gets China Approval for Staphylococcus Aureus Detection Kit
12-09-25	Sansure Biotech Inc. acquired an additional 10% stake in Hunan Sanway SepSMART Ltd from Sepset Biosciences Inc. for CNY 5 million.
29-08-25	Sansure Biotech H1 net profit up 3.8% Y/Y
29-08-25	Sansure Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2025
28-07-25	Sansure Biotech Gets Device Registration Certificates for Two Products
13-06-25	Sansure Biotech to Buy 10% Stake in SepsisRe Biotech for 5 Million Yuan
13-06-25	Sansure Biotech Inc. agreed to acquire 10% stake in Hunan Shengwei Sirui Biotechnology Co., Ltd. from Sepset Biosciences Inc for CNY 5 million.
12-06-25	Hunan Shengwei Sirui Biotechnology Co., Ltd. announced that it has received funding from Sansure Biotech Inc.
28-05-25	GeneMind Biosciences Co., Ltd. announced that it has received CNY 280 million in funding from a group of investors
20-05-25	Declaration of Voting Results by Sansure Biotech
09-05-25	Sansure Biotech to Invest 100 Million Yuan Into Subsidiary's Capital to Boost POC Testing Chain
09-05-25	Hunan Shengwei Kun Teng Biotechnology Co., Ltd. announced that it expects to receive CNY 210 million in funding from Changsha Shengwei Rongquan Venture Capital Co., Ltd, Sansure Biotech Inc., Jiaxing Kangwo Tuojie Venture Capital Partnership Enterprise (Limited Partnership)
08-05-25	Sansure Biotech Receives Shareholder Proposal from Lizhong Dai
28-04-25	Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
15-04-25	Sansure Biotech's Unit Gets Nod to Build Production Line for Recombinant Human Growth Hormone Injection
07-03-25	GeneMind Biosciences Company Limited announced that it expects to receive CNY 130 million in funding from Sansure Biotech Inc.
27-02-25	Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
26-02-25	Sansure Biotech to Acquire 54% Stake in Hong'an Jiyuan Biotechnology
25-02-25	Sansure Biotech Completes Acquisition of Zhongshan Haiji

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen MarketScreener-artikels MarketScreener-analyses Ideeën voor de handel

Andere talen Sansure Biotech Inc.

Aandelen

688289

CNE1000043J1

Medische apparatuur, benodigdheden & distributie

Andere talen

Filters